Phosphatidylinositol metabolism in lymphocytes of chronic alcoholic patients after anti-CD3 stimulation.
The immunological alterations observed in chronic alcoholic patients may be due to alterations of signal transduction across the lymphocyte membrane. Upon binding of mitogens or antigens to specific plasma membrane receptors, the activation of phospholipase C leads to the hydrolysis of inositol phospholipids, producing inositol phosphates and diacylglycerol. One of the early events in lymphocyte activation is an increase of intracellular calcium concentration, due to both an influx from extracellular fluid and a release from intracellular stores mediated by inositol phosphates. In this study we verified whether the diminished mobilization of intracellular calcium, previously observed in alcoholics, is caused by alteration in phosphoinositide turnover. We evaluated total inositol phosphate production in peripheral blood lymphocytes after anti-CD3 stimulation, comparing control subjects and alcoholic patients. Lymphocyte activation generated inositol phosphates in both controls and alcoholics, but to a different extent, inositol phosphate production being significantly higher in controls than in alcoholics. This reduction in inositol phosphate production could be accounted either to an inhibition of PLC activity or to a modified affinity of phospholipase C for its own substrates, i.e., phosphoinositides, which fatty acid composition has been previously demonstrated to be greatly different in alcoholics in comparison to healthy subjects.
Hrelia
S
S
Department of Biochemistry G. Moruzzi, University of Bologna, Italy.
Celadon
M
M
Bordoni
A
A
Castelli
E
E
Foschi
F G
FG
Stefanini
G F
GF
Rossi
C A
CA
Biagi
P L
PL
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000276:immunology* / Q000378:metabolism; D017252:CD3 Complex / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000276:immunology / Q000378:metabolism*; D015398:Signal Transduction / Q000276:immunology
D017252:CD3 Complex; D016853:Muromonab-CD3; D010716:Phosphatidylinositols